China Pharma Holdings (CPHI) Gross Profit (2010 - 2026)
China Pharma Holdings (CPHI) posted Gross Profit of $285487.0 for Q1 2026, up 89.35% on a QoQ basis from $150775.0 in Q4 2025, and up 309.82% year-over-year from $69661.1 in Q1 2025.
China Pharma Holdings (CPHI) Gross Profit (2010 - 2026) Analysis & Trends
China Pharma Holdings' Gross Profit history runs 17 years deep, the most recent figure standing at $285487.0 for Q1 2026.
- Quarterly Gross Profit rose 309.82% year-over-year to $285487.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $289598.0 (up 115.81% YoY) and the FY2025 annual result came in at -$131950.0, up 93.35% from the prior year.
- Gross Profit was $285487.0 for Q1 2026 at China Pharma Holdings, up from $150775.0 in the prior quarter.
- Across five years, Gross Profit topped out at $285487.0 in Q1 2026 and bottomed at -$1.0 million in Q2 2024.
- A 5-year average of -$153359.5 and a median of -$137756.0 in 2022 frame the typical range for Gross Profit.
- Annual changes were most pronounced in 2024 — Gross Profit plunged 592.34% — and 2026, when it jumped 309.82%.
- China Pharma Holdings' Gross Profit stood at $42682.0 in 2022, then tumbled by 285.46% to -$79158.0 in 2023, then sank by 102.87% to -$160589.0 in 2024, then jumped by 193.89% to $150775.0 in 2025, then soared by 89.35% to $285487.0 in 2026.
- Business Quant data shows CPHI's Gross Profit at $285487.0 in Q1 2026, $150775.0 in Q4 2025, and -$59654.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | China Pharma Holdings | 629,344.02 | 460,870.02 | 285,487.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 285,487.00 |
| Mar 31, 2026 | 285,487.00 |
| Dec 31, 2025 | 150,775.00 |
| Dec 31, 2025 | 150,775.00 |
| Sep 30, 2025 | -59,654.00 |
| Sep 30, 2025 | -59,654.00 |
| Jun 30, 2025 | -87,010.00 |
| Jun 30, 2025 | -87,010.00 |
| Mar 31, 2025 | -136,061.00 |
| Mar 31, 2025 | -136,061.00 |
| Dec 31, 2024 | -160,589.00 |
| Dec 31, 2024 | -160,589.00 |
| Sep 30, 2024 | -519,649.00 |
| Sep 30, 2024 | -519,649.00 |
| Jun 30, 2024 | -1.02 Mn |
| Jun 30, 2024 | -1.02 Mn |
| Mar 31, 2024 | -290,024.00 |
| Mar 31, 2024 | -290,024.00 |
| Dec 31, 2023 | -79,158.00 |
| Dec 31, 2023 | -79,158.00 |